Clinical Differences between Community-Acquired <i>Mycoplasma pneumoniae</i> Pneumonia and COVID-19 Pneumonia

Clinical Differences between Community-Acquired <i>Mycoplasma pneumoniae</i> Pneumonia and COVID-19 Pneumonia

<i>Mycoplasma</i><i>pneumoniae</i> is one of the major causative pathogens of community-acquired pneumonia (CAP). <i>M. pneumoniae</i> CAP is clinically and radiologically distinct from bacterial CAPs. One feature of the Japanese Respiratory Society (JRS) guidelin...

Full description

Bibliographic Details
Main Authors: Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
clinical differences
community-acquired pneumonia
<i>Mycoplasma pneumoniae</i>
SARS-CoV-2
COVID-19
Online Access:https://www.mdpi.com/2077-0383/11/4/964

Internet

https://www.mdpi.com/2077-0383/11/4/964

Similar Items